A carregar...
Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
Although sodium valproate (VPA)-induced hepatic encephalopathy is a well-recognized entity, VPA can occasionally produce encephalopathy secondary to hyperammonemia in the presence of normal hepatic function, namely valproate-induced non-hepatic hyperammonemic encephalopathy (VNHE). Known risk factor...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2924516/ https://ncbi.nlm.nih.gov/pubmed/20814502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0972-2327.64638 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|